SPOP Polyclonal antibody 16750-1-AP proteintech

$149.00
In stock
SKU
16750-1-AP
Catalog No.SizePrice (USD)
16750-1-AP-20UL20 μL$149.00
16750-1-AP-150UL150 μL$449.00
Catalog Number16750-1-AP
Synonymsspeckle type POZ protein, Speckle-type POZ protein, TEF2
HostRabbit
Reactivityhuman, mouse, rat
FormLiquid
FormulationPBS, Azide, Glycerol
ApplicationsWB, IHC, IF/ICC, IP, CoIP, RIP, ELISA
ApplicationsWB, IF/ICC, IP, ELISA
Host / IsotypeRabbit / IgG
Tested Applications — Positive WB detected inHeLa cells, HepG2 cells, PC-3 cells
Tested Applications — Positive IP detected inHepG2 cells
Tested Applications — Positive IF/ICC detected inHepG2 cells
Recommended Dilutions — Western Blot (WB)WB : 1:500-1:5000
Recommended Dilutions — Immunoprecipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Recommended Dilutions — Immunofluorescence (IF)/ICCIF/ICC : 1:50-1:500
Positive WB detected inHeLa cells, HepG2 cells, PC-3 cells
Positive IP detected inHepG2 cells
Positive IF/ICC detected inHepG2 cells
Western Blot (WB)WB : 1:500-1:5000
Immunoprecipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Immunofluorescence (IF)/ICCIF/ICC : 1:50-1:500
Tested Reactivityhuman, mouse, rat
Cited Reactivityhuman, mouse, rat
ClassPolyclonal
TypeAntibody
ImmunogenCatNo: Ag10215 Product name: Recombinant human SPOP protein Source: e coli. -derived, PGEX-4T Tag: GST Domain: 1-374 aa of BC003385 Sequence: MSRVPSPPPPAEMSSGPVAESWCYTQIKVVKFSYMWTINNFSFCREEMGEVIKSSTFSSGANDKLKWCLRVNPKGLDEESKDYLSLYLLLVSCPKSEVRAKFKFSILNAKGEETKAMESQRAYRFVQGKDWGFKKFIRRDFLLDEANGLLPDDKLTLFCEVSVVQDSVNISGQNTMNMVKVPECRLADELGGLWENSRFTDCCLCVAGQEFQAHKAILAARSPVFSAMFEHEMEESKKNRVEINDVEPEVFKEMMCFIYTGKAPNLDKMADDLLAAADKYALERLKVMCEDALCSNLSVENAAEILILADLHSADQLKTQAVDFINYHASDVLETSGWKSMVVSHPHLVAEAYRSLASAQCPFLGPPRKRLKQS Predict reactive species
Full Namespeckle-type POZ protein
Calculated Molecular Weight374 aa, 42 kDa
Observed Molecular Weight42 kDa
GenBank Accession NumberBC003385
Gene SymbolSPOP
Gene ID (NCBI)8405
RRIDAB_2756394
ConjugateUnconjugated
Purification MethodAntigen affinity purification
UNIPROT IDO43791
Storage BufferPBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20 o C storage. 20ul sizes contain 0.1% BSA.
IF protocol for SPOP antibody 16750-1-APDownload protocol
IP protocol for SPOP antibody 16750-1-APDownload protocol
WB protocol for SPOP antibody 16750-1-APDownload protocol
humanWB Mol Cancer SPOP-mediated ubiquitination and degradation of PDK1 suppresses AKT kinase activity and oncogenic functions. Authors - Qiwei Jiang KD Validated View Article
mouseMol Cell DNA Damage Promotes TMPRSS2-ERG Oncoprotein Destruction and Prostate Cancer Suppression via Signaling Converged by GSK3β and WEE1. Authors - Zhe Hong View Article
Mada (Verified Customer) (01-23-2026)Support très compétent, nos commandes sont prises en charge immédiatement et le suivi est très fluide. Applications: Protein purification
Citations100
DilutionsWB : 1:500-1:5000 IP : 0.5-4.0 ug for IP and 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate for WB IF/ICC : 1:50-1:500
IsotypeIgG
ClonalityPolyclonal
Clone Number-
ConjugationUnconjugated

The SPOP (TEF2) protein was previously identified as an autoantigen in a patient with scleroderma pigmentosum. SPOP (speckle-type POZ protein), also known as TEF2, HIB homolog 1 or Roadkill homolog 1, is a member of the Tdpoz family containing one N-terminal MATH (Meprin and TRAF Homology) domain and one C-terminal BTB/POZ domain. SPOP can exist as a homodimer and is expressed in a variety of tissues localizing to the nucleus. BTB-mediated SPOP dimers form linear oligomers via BACK domain dimerization, and we determine the concentration-dependent populations of the resulting oligomeric species (PMID: 27220849 ). Through an interaction with CUL-3, SPOP is involved in ubiquitinylation and protein degradation. SPOP specifically interacts with CUL-3 via its BTB/POZ domain and recruits substrates to the CUL-3-based ubiquitin ligase via its MATH domain. Substrates recruited by SPOP and targeted for ubiquitylation via the CUL-3/SPOP complex include PDX-1, Bmi-1, MacroH2A, PIPK II ∫ and Daxx. These substrates are subsequently degraded by the proteasome. In addition, SPOP itself becomes ubiquitylated by the CUL-3-based ubiquitin ligase and is targeted for proteasomal degradation. Protocols Product Specific Protocols IF protocol for SPOP antibody 16750-1-AP Download protocol IP protocol for SPOP antibody 16750-1-AP Download protocol WB protocol for SPOP antibody 16750-1-AP Download protocol Standard Protocols Click here to view our Standard Protocols

Publications

  1. Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance.
    Journal: Nature | Authors: Jinfang Zhang KO Validated | Species: human | Application: WB,IP
  2. Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4.
    Journal: Nat Med | Authors: Xiangpeng Dai KO Validated | Species: human | Application: WB
  3. Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activation.
    Journal: Nat Med | Authors: Pingzhao Zhang KD Validated | Species: human | Application: WB
  4. ILF3 is a substrate of SPOP for regulating serine biosynthesis in colorectal cancer.
    Journal: Cell Res | Authors: Kai Li KD Validated | Species: human | Application: WB
  5. DNA Damage Promotes TMPRSS2-ERG Oncoprotein Destruction and Prostate Cancer Suppression via Signaling Converged by GSK3β and WEE1.
    Journal: Mol Cell | Authors: Zhe Hong | Species: mouse
  6. SPOP-mediated ubiquitination and degradation of PDK1 suppresses AKT kinase activity and oncogenic functions.
    Journal: Mol Cancer | Authors: Qiwei Jiang KD Validated | Species: human | Application: WB
  7. SPOP negatively regulates Toll-like receptor-induced inflammation by disrupting MyD88 self-association.
    Journal: Cell Mol Immunol | Authors: Yun-Hong Hu | Species: human | Application: WB
  8. The E2F1-miR-520/372/373-SPOP axis modulates progression of renal carcinoma.
    Journal: Cancer Res | Authors: Meng Ding | Species: human | Application: WB,IF
  9. BRD4 levels determine the response of human lung cancer cells to BET degraders that potently induce apoptosis through suppression of Mcl-1.
    Journal: Cancer Res | Authors: Dan Zong | Species: human | Application: WB
  10. Phosphorylation and Stabilization of PD-L1 by CK2 Suppresses Dendritic Cell Function.
    Journal: Cancer Res | Authors: Xixi Zhao | Species: human | Application: WB
  11. Interpretable deep learning framework for mapping E3-substrate binding interfaces.
    Journal: Nat Commun | Authors: Dianke Li
  12. SPOP mutation induces replication over-firing by impairing Geminin ubiquitination and triggers replication catastrophe upon ATR inhibition.
    Journal: Nat Commun | Authors: Jian Ma | Species: human | Application: WB
  13. Genetic fusions favor tumorigenesis through degron loss in oncogenes.
    Journal: Nat Commun | Authors: Jing Liu | Species: human | Application: WB,IP
  14. G3BP1 inhibits Cul3SPOP to amplify AR signaling and promote prostate cancer.
    Journal: Nat Commun | Authors: Chandrani Mukhopadhyay | Species: human | Application: WB,IP,IF
  15. SPOP mutation induces replication over-firing by impairing Geminin ubiquitination and triggers replication catastrophe upon ATR inhibition.
    Journal: Nat Commun | Authors: Jian Ma | Species: human | Application: WB
  16. SPOP mutation induces DNA methylation via stabilizing GLP/G9a.
    Journal: Nat Commun | Authors: Jianong Zhang | Species: human | Application: WB
  17. TRABID overexpression enables synthetic lethality to PARP inhibitor via prolonging 53BP1 retention at double-strand breaks
    Journal: Nat Commun | Authors: Jian Ma | Species: human | Application: CoIP
  18. Interpretable deep learning framework for mapping E3-substrate binding interfaces.
    Journal: Nat Commun | Authors: Dianke Li
  19. SPOP Promotes Ubiquitination and Degradation of the ERG Oncoprotein to Suppress Prostate Cancer Progression.
    Journal: Mol Cell | Authors: Wenjian Gan | Species: human | Application: WB
  20. DUB3 Promotes BET Inhibitor Resistance and Cancer Progression by Deubiquitinating BRD4.
    Journal: Mol Cell | Authors: Xin Jin | Species: human | Application: WB
  21. Truncated ERG Oncoproteins from TMPRSS2-ERG Fusions Are Resistant to SPOP-Mediated Proteasome Degradation.
    Journal: Mol Cell | Authors: Jian An | Species: human | Application: WB,IHC
  22. DNA Damage Promotes TMPRSS2-ERG Oncoprotein Destruction and Prostate Cancer Suppression via Signaling Converged by GSK3β and WEE1.
    Journal: Mol Cell | Authors: Zhe Hong | Species: mouse
  23. SPOP promotes transcriptional expression of DNA repair and replication factors to prevent replication stress and genomic instability.
    Journal: Nucleic Acids Res | Authors: Kim Hjorth-Jensen | Species: human | Application: WB,IF
  24. Inhibition of METTL14 overcomes CDK4/6 inhibitor resistance driven by METTL14-m6A-E2F1-axis in ERα-positive breast cancer
    Journal: J Nanobiotechnology | Authors: Chenlin Liu | Species: human | Application: WB,CoIP
  25. SPOP promotes transcriptional expression of DNA repair and replication factors to prevent replication stress and genomic instability.
    Journal: Nucleic Acids Res | Authors: Kim Hjorth-Jensen | Species: human | Application: WB,IF
  26. SPOP promotes ATF2 ubiquitination and degradation to suppress prostate cancer progression.
    Journal: J Exp Clin Cancer Res | Authors: Jian Ma | Species: human | Application: WB
  27. Canagliflozin primes antitumor immunity by triggering PD-L1 degradation in endocytic recycling
    Journal: J Clin Invest | Authors: Ling Ding | Species: human | Application: WB,IF
  28. SPOP suppresses tumorigenesis by regulating Hedgehog/Gli2 signaling pathway in gastric cancer.
    Journal: J Exp Clin Cancer Res | Authors: Chunyan Zeng | Species: human | Application: WB,IHC,IF,CoIP
  29. Cancer-associated SPOP mutations enlarge nuclear size and facilitate nuclear envelope rupture upon farnesyltransferase inhibitor treatment
    Journal: J Clin Invest | Authors: Zixi Wang | Species: human | Application: IF
  30. SPOP and OTUD7A Control EWS-FLI1 Protein Stability to Govern Ewing Sarcoma Growth.
    Journal: Adv Sci (Weinh) | Authors: Siyuan Su | Species: human | Application: WB
  31. Targeting Nuclear Receptor Coactivator SRC-1 Prevents Colorectal Cancer Immune Escape by Reducing Transcription and Protein Stability of PD-L1
    Journal: Adv Sci (Weinh) | Authors: Yilin Hong | Species: human | Application: WB
  32. Network Medicine-Based Strategy Identifies Maprotiline as a Repurposable Drug by Inhibiting PD-L1 Expression via Targeting SPOP in Cancer
    Journal: Adv Sci (Weinh) | Authors: Saisai Tian | Species: human | Application: WB,IF
  33. CircLRBA Promotes Epithelial-Mesenchymal Transition, Immune Evasion, Chemoimmunotherapy Resistance and Metastasis Through Stabilizing Twist1.
    Journal: Adv Sci (Weinh) | Authors: Xiaosong Wang | Species: human,mouse | Application: WB,RIP,IP,IF
  34. CSN6-SPOP-HMGCS1 Axis Promotes Hepatocellular Carcinoma Progression via YAP1 Activation
    Journal: Adv Sci (Weinh) | Authors: Kai Li | Species: human | Application: WB
  35. Aldehyde Dehydrogenase 2 Mediates Alcohol-Induced Colorectal Cancer Immune Escape through Stabilizing PD-L1 Expression.
    Journal: Adv Sci (Weinh) | Authors: Hong Zhang | Species: human | Application: WB
  36. ATM-phosphorylated SPOP contributes to 53BP1 exclusion from chromatin during DNA replication.
    Journal: Sci Adv | Authors: Dejie Wang | Species: human
  37. ATM-phosphorylated SPOP contributes to 53BP1 exclusion from chromatin during DNA replication.
    Journal: Sci Adv | Authors: Dejie Wang | Species: human
  38. SPOP mutations promote tumor immune escape in endometrial cancer via the IRF1-PD-L1 axis
    Journal: Cell Death Differ | Authors: Kun Gao | Species: human | Application: WB
  39. TRIM24-mediated K27-linked ubiquitination of ULK1 alleviates energy stress-induced autophagy and promote prostate cancer growth in the context of SPOP mutation
    Journal: Cell Death Differ | Authors: Shimin Chen
  40. Histone methyltransferase KMT2D targets the SPOP-G3BP1 axis to enhance AR stability and drive castration-resistant prostate cancer progression.
    Journal: Mol Biomed | Authors: Haoran Wen | Species: human | Application: WB
  41. SPOP and HAUSP bidirectionally regulate LZTS2 ubiquitination to modulate the Wnt pathway.
    Journal: Cell Death Dis | Authors: Yanran Deng | Species: human | Application: WB,IP,CoIP
  42. Reduced YTHDF2 inhibits PD-L1 expression by stabilizing m(6)A-containing SPOP mRNA in colorectal cancer.
    Journal: Cell Death Dis | Authors: Xian Xu | Species: human | Application: WB
  43. ELK3 destabilization by speckle-type POZ protein suppresses prostate cancer progression and docetaxel resistance
    Journal: Cell Death Dis | Authors: Cheol-Jung Lee | Species: human | Application: WB,IP
  44. SPOP suppresses pancreatic cancer progression by promoting the degradation of NANOG.
    Journal: Cell Death Dis | Authors: Peng Tan | Species: human | Application: WB
  45. SPOP and HAUSP bidirectionally regulate LZTS2 ubiquitination to modulate the Wnt pathway.
    Journal: Cell Death Dis | Authors: Yanran Deng | Species: human | Application: WB,IP,CoIP
  46. Tumor suppressor SPOP ubiquitinates and degrades EglN2 to compromise growth of prostate cancer cells.
    Journal: Cancer Lett | Authors: Linli Zhang | Species: human | Application: WB
  47. Prostate cancer-associated mutation in SPOP impairs its ability to target Cdc20 for poly-ubiquitination and degradation.
    Journal: Cancer Lett | Authors: Fei Wu | Species: human | Application: WB
  48. CUL3/SPOP complex prevents immune escape and enhances chemotherapy sensitivity of ovarian cancer cells through degradation of PD-L1 protein
    Journal: J Immunother Cancer | Authors: Min Dong | Species: human | Application: WB,IHC
  49. CUL3/SPOP complex prevents immune escape and enhances chemotherapy sensitivity of ovarian cancer cells through degradation of PD-L1 protein
    Journal: J Immunother Cancer | Authors: Min Dong | Species: human | Application: WB,IHC
  50. TMEM160 promotes tumor immune evasion and radiotherapy resistance via PD-L1 binding in colorectal cancer
    Journal: Cell Commun Signal | Authors: Xiaofeng Dai | Species: human | Application: WB,IP,CoIP
  51. Endometrial cancer (EC) derived G3BP1 overexpression and mutant promote EC tumorigenesis and metastasis via SPOP/ERα axis
    Journal: Cell Commun Signal | Authors: Yidong Ge | Species: human | Application: WB,CoIP
  52. SPOP promotes ubiquitination and degradation of LATS1 to enhance kidney cancer progression.
    Journal: EBioMedicine | Authors: Lixia Wang | Species: human | Application: WB,IHC
  53. LMNB2-mediated high PD-L1 transcription triggers the immune escape of hepatocellular carcinoma
    Journal: Cell Death Discov | Authors: Yuxuan Li | Species: human | Application: WB,IHC
  54. The nuclear ubiquitin ligase adaptor SPOP is a conserved regulator of C9orf72 dipeptide toxicity
    Journal: Proc Natl Acad Sci U S A | Authors: Carley Snoznik | Species: rat | Application: WB
  55. The nuclear ubiquitin ligase adaptor SPOP is a conserved regulator of C9orf72 dipeptide toxicity
    Journal: Proc Natl Acad Sci U S A | Authors: Carley Snoznik | Species: rat | Application: WB
  56. AMPK Promotes SPOP-Mediated NANOG Degradation to Regulate Prostate Cancer Cell Stemness.
    Journal: Dev Cell | Authors: Xinbo Wang | Species: human | Application: WB
  57. SPOP Promotes Nanog Destruction to Suppress Stem Cell Traits and Prostate Cancer Progression.
    Journal: Dev Cell | Authors: Jinfang Zhang | Species: human | Application: WB
  58. O-GlcNAcylation of SPOP promotes carcinogenesis in hepatocellular carcinoma
    Journal: Oncogene | Authors: Peng Zhou | Species: human | Application: WB,IHC,IF,CoIP
  59. Substrate-dependent interaction of SPOP and RACK1 aggravates cardiac fibrosis following myocardial infarction
    Journal: Cell Chem Biol | Authors: Wanqi Yang | Species: mouse,human | Application: WB,IF
  60. Parp7 generates an ADP-ribosyl degron that controls negative feedback of androgen signaling
    Journal: EMBO J | Authors: Krzysztof Wierbiłowicz | Species: human | Application: WB
  61. Additive effect of CD73 inhibitor in colorectal cancer treatment with CDK4/6 inhibitor through regulation of PD-L1.
    Journal: Cell Mol Gastroenterol Hepatol | Authors: Ji-Yoon Noh | Species: human | Application: WB
  62. Dual inhibition of AKT-mTOR and AR signaling by targeting HDAC3 inPTEN- orSPOP-mutated prostate cancer.
    Journal: EMBO Mol Med | Authors: Yuqian Yan | Species: human | Application: WB
  63. The novel BET-CBP/p300 dual inhibitor NEO2734 is active in SPOP mutant and wild-type prostate cancer.
    Journal: EMBO Mol Med | Authors: Yuqian Yan | Species: human | Application: WB
  64. c-Myb facilitates immune escape of esophageal adenocarcinoma cells through the miR-145-5p/SPOP/PD-L1 axis.
    Journal: Clin Transl Med | Authors: Lan Zhang | Species: mouse,human | Application: WB,RIP,IHC
  65. Elevating PLK1 overcomes BETi resistance in prostate cancer via triggering BRD4 phosphorylation-dependent degradation in mitosis
    Journal: Cell Rep | Authors: Yanquan Zhang | Species: human | Application: WB
  66. Harnessing the E3 ligase SPOP for targeted degradation of the NUP98::KDM5A fusion oncoprotein.
    Journal: Cell Rep | Authors: Ecem Kirkiz | Species: human | Application: WB
  67. Harnessing the E3 ligase SPOP for targeted degradation of the NUP98::KDM5A fusion oncoprotein.
    Journal: Cell Rep | Authors: Ecem Kirkiz | Species: human | Application: WB
  68. E3 ligase substrate adaptor SPOP fine-tunes the UPR of pancreatic β cells
    Journal: Genes Dev | Authors: Alexis U Oguh
  69. The orphan nuclear receptor SHP regulates ER stress response by inhibiting XBP1s degradation.
    Journal: Genes Dev | Authors: Shengyi Sun | Species: human | Application: WB
  70. Clinicopathological and prognostic significance of speckle-type POZ protein in cancers: a systematic review and meta-analysis.
    Journal: Cancer Cell Int | Authors: Yan He | Species: human | Application: IHC
  71. SPOP-mediated RIPK3 destabilization desensitizes LPS/sMAC/zVAD-induced necroptotic cell death
    Journal: Cell Mol Life Sci | Authors: Ga-Eun Lee | Species: human | Application: WB,CoIP
  72. BCLAF1 binds SPOP to stabilize PD-L1 and promotes the development and immune escape of hepatocellular carcinoma
    Journal: Cell Mol Life Sci | Authors: Zongdong Yu | Species: human | Application: WB,IHC,IF
  73. Knockdown of ZBTB7A inhibits cell proliferation of breast cancer through regulating the ubiquitination of estrogen receptor alpha.
    Journal: Life Sci | Authors: Xiao Xiao | Species: human | Application: WB
  74. The role of IGF2BP3/SPOP/c-Myc loop in paclitaxel resistance of endometrial cancer
    Journal: Commun Biol | Authors: Yidong Ge | Application: WB,RIP
  75. Identification of SPOP related metabolic pathways in prostate cancer.
    Journal: Oncotarget | Authors: Min Yan | Species: human | Application: WB
  76. Cullin 3SPOP ubiquitin E3 ligase promotes the poly-ubiquitination and degradation of HDAC6.
    Journal: Oncotarget | Authors: Yuyong Tan | Species: human | Application: WB
  77. Deficiency in SPOP-mediated ubiquitination and degradation of TIAM1 promotes gastric cancer progression
    Journal: Biochim Biophys Acta Mol Basis Dis | Authors: Fang Liu | Species: human | Application: WB
  78. SPOP promotes CDCA5 degradation to regulate prostate cancer progression via the AKT pathway.
    Journal: Neoplasia | Authors: Zhenzhen Luo | Species: human | Application: WB,IP
  79. CircXPO6 promotes breast cancer progression through competitively inhibiting the ubiquitination degradation of c-Myc
    Journal: Mol Cell Biochem | Authors: Aiqi Xu | Species: human | Application: WB
  80. miR-372 and miR-373 enhance the stemness of colorectal cancer cells by repressing differentiation signaling pathways.
    Journal: Mol Oncol | Authors: Lu-Qin Wang | Species: human | Application: WB
  81. SPOP promotes CREB5 ubiquitination to inhibit MET signaling in liver cancer
    Journal: Biochim Biophys Acta Mol Cell Res | Authors: De-Ao Gong | Species: human | Application: WB,IHC,CoIP
  82. Neural Stem Cell Extracellular Vesicles Carrying YBX1 Inhibited Neuronal Pyroptosis Through Increasing m6A-modified GPR30 Stability and Expression in Ischemic Stroke
    Journal: Transl Stroke Res | Authors: Jun Peng | Species: rat
  83. S119N Mutation of the E3 Ubiquitin Ligase SPOP Suppresses SLC7A1 Degradation to Regulate Hepatoblastoma Progression.
    Journal: Mol Ther Oncolytics | Authors: Weijing He | Species: human | Application: WB,IF,CoIP
  84. SUFU promotes GLI activity in a Hedgehog-independent manner in pancreatic cancer
    Journal: Biochem J | Authors: Brooke D Paradise | Species: human | Application: WB
  85. Dysregulation of INF2-mediated mitochondrial fission in SPOP-mutated prostate cancer.
    Journal: PLoS Genet | Authors: Xiaofeng Jin | Species: human | Application: WB
  86. Sequence rules for a long SPOP-binding degron required for protein ubiquitylation
    Journal: Biochem J | Authors: Linda Makhlouf | Species: human | Application: WB
  87. SPOP inhibits mice pancreatic stellate cell activation by promoting FADD degradation in cerulein-induced chronic pancreatitis.
    Journal: Exp Cell Res | Authors: Peng Tan | Species: mouse | Application: WB,IHC
  88. LRP5 competes for SPOP binding to enhance tumorigenesis mediated by Daxx and PD-L1 in prostate cancer
    Journal: Exp Cell Res | Authors: Sishun Gan | Species: human | Application: WB
  89. Hypoxia-induced SPOP attenuates the mobility of trophoblast cells through inhibition of the PI3K/AKT/GSK3β pathway.
    Journal: Cell Biol Int | Authors: Dong Yuan | Species: human | Application: WB,IF
  90. Ablation of the GDP-fucose transporter suppresses lung cancer cell proliferation and migration by reducing expression of PD-L1
    Journal: J Cancer | Authors: Yingshu Zhang | Species: human | Application: WB
  91. PINX1 inhibits proliferation and cisplatin resistance in nasopharyngeal carcinoma by promoting ILF3 ubiquitination
    Journal: Am J Cancer Res | Authors: Ni Zhou | Species: human | Application: WB,IF
  92. SPOP targets oncogenic protein ZBTB3 for destruction to suppress endometrial cancer.
    Journal: Am J Cancer Res | Authors: Xiaofeng Jin | Species: Human
  93. Tumor suppressor SPOP mediates the proteasomal degradation of progesterone receptors (PRs) in breast cancer cells.
    Journal: Am J Cancer Res | Authors: Kun Gao | Species: human | Application: WB,IP
  94. SPOP regulates the DNA damage response and lung adenocarcinoma cell response to radiation.
    Journal: Am J Cancer Res | Authors: Yiping Dong | Species: human | Application: WB
  95. Sorting nexin 6 interacts with Cullin3 and regulates programmed death ligand 1 expression.
    Journal: FEBS Lett | Authors: Chinmoy Ghosh | Species: human | Application: WB
  96. SPOP is essential for DNA-protein cross-link repair in prostate cancer cells: SPOP-dependent removal of topoisomerase 2A from the topoisomerase 2A-DNA cleavage complex.
    Journal: Mol Biol Cell | Authors: Ryuta Watanabe | Species: human | Application: WB,IF
  97. Snail promotes prostate cancer migration by facilitating SPOP ubiquitination and degradation.
    Journal: Biochem Biophys Res Commun | Authors: Wei Lv | Species: human | Application: WB
  98. Speckle-type POZ protein suppresses hepatocellular carcinoma cell migration and invasion via ubiquitin-dependent proteolysis of SUMO1/sentrin specific peptidase 7.
    Journal: Biochem Biophys Res Commun | Authors: Piyou Ji | Species: human | Application: WB,IHC
  99. Loss of Speckle-Type POZ Protein Promotes Prostate Cancer Cell Migration and Invasion Through Upregulation of MCP-1.
    Journal: Med Sci Monit | Authors: Junlin Shi | Species: human | Application: WB
  100. SPOP Regulates The Biological Mechanism Of Ovarian Cancer Cells Through The Hh Signaling Pathway.
    Journal: Onco Targets Ther | Authors: Yanxi Li | Species: human | Application: WB,IHC
  101. SPOP-mediated ZMYND8 ubiquitination and phase separation exclusion drives mTOR inhibitor resistance in kidney cancer.
    Journal: Nat Commun | Authors: Bo Tang | Species: human | Application: WB,IHC
  102. Switching of transcriptional control from interferon regulatory factor 2 to interferon regulatory factor 1 drives innate immune cell activation.
    Journal: Cell | Authors: Cristhian Cadena | Species: mouse | Application: WB

Reviews

Write Your Own Review
You're reviewing:SPOP Polyclonal antibody 16750-1-AP proteintech
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.